GABAeron

GABAeron is a biopharmaceutical company focused on developing stem cell-based therapies and generating protective small molecules to treat neurological disorders. Our approach combines precision medicine, utilizing genetic information for patient stratification, regenerative medicine (iPSC-derived cell therapy), and drug intervention (small molecule drugs) to replace and restore lost or injured neural cells. The treatment plans aim to protect the function of the most vulnerable cell populations in the brains of patients with neurodegenerative and neurodevelopmental disorders. The primary target is apoE4-related neurological diseases.